Exosomes Market Size To Reach $1.2 Billion By 2033

Exosomes Market Growth & Trends

The global exosomes market size is expected to reach USD 1.2 billion by 2033, registering a CAGR of 23.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).

Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification. The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.

Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.

Similarly, in February 2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the exosome therapeutics and expand the company’s leading exome platform DeliverEX globally. However, stringent regulations pertaining to the approval and commercialization of exosome products may hamper the growth of the industry over the forecast period. In addition, technical difficulties associated with the implementation of exosomes in various applications may hamper the growth during the study period. Some of the major challenges include the lack of efficient transfection strategies and the need for optimization of purification methods. Such, challenges are anticipated to impede the market growth.

 Request a free sample copy or view report summary: Exosomes Market Report

Exosomes Market Report Highlights

• The growing recognition of exosomes as efficient drug delivery vehicles is driving market expansion. Their ability to cross biological barriers, along with low immunogenicity and minimal toxicity, is expanding their use across therapeutics, diagnostics, and vaccine development, positioning them as a key tool in targeted and personalized medicine.

• The exosomes industry exhibits significant innovation, propelled by advances in biotechnology and regenerative medicine. These nanoscale vesicles are increasingly harnessed for targeted drug delivery, diagnostics, and therapeutic applications.

• For instance, in January 2025, Marijuana, Inc. acquired Exousia AI, entering the exosome market. The company advanced plant-based exosome technologies for drug delivery, expanded oncology and dermatology research, and targeted growing cosmeceutical applications, supporting commercialization and therapeutic development initiatives. Such dynamic activities are accelerating merger and acquisition activity in the exosomes industry.

• The kits and reagents segment captured the largest market share of 46.2% in 2025. Leading companies are introducing innovative kits and reagents to expand exosomes' versatility

• The downstream analysis segment accounted for the largest market share of 59.1% in 2025. The downstream analysis includes detection, quantification, labeling, and modification or engineering of exosomes.

• The cancer segment held the largest market share of 33.2% in 2025. This can be attributed to the broad range of exosome applications in cancer diagnosis, prognosis, and treatment.

• The pharmaceutical & biotechnology companies segment captured the largest revenue share of 50.6% in 2025. The segment is experiencing growth driven by rising demand for extracellular vesicle-based therapeutics and vaccines.

• The North America exosomes industry accounted for the largest share of 57.2% in 2025 and is projected to grow at the fastest rate over the forecast period.

Exosomes Market Segmentation

Grand View Research has segmented the global exosomes market report based on product & service, workflow, application, end use, and region:

Exosomes Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

• Kits & Reagents

• Instruments

• Services

Exosomes Workflow Outlook (Revenue, USD Million, 2021 - 2033)

• Isolation Methods

  • Ultracentrifugation

  • Immunocapture on beads

  • Precipitation

  • Filtration

  • Others

• Downstream Analysis

  • Cell surface marker analysis using flow cytometry

  • Protein analysis using blotting & ELISA

  • RNA analysis with NGS & PCR

  • Proteomic analysis using mass spectroscopy

  • Others

Exosomes Application Outlook (Revenue, USD Million, 2021 - 2033)

• Cancer

• Neurodegenerative diseases

• Cardiovascular diseases

• Infectious diseases

• Others

Exosomes End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & biotechnology companies

• Hospitals & diagnostics centers

• Academic & research institutes

Exosomes Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

  • Singapore

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Exosomes Market

• Danaher Corporation

• Hologic Inc.

• Fujifilm Holdings Corporation

• Lonza

• Miltenyi Biotec

• Bio-Techne Corporation

• QIAGEN

• Thermo Fisher Scientific, Inc.

• Abcam plc

• RoosterBio, Inc.